Gonzalez-Parra Emilio, Gonzalez-Casaus Maria Luisa, Arenas Maria Dolores, Sainz-Prestel Valeria, Gonzalez-Espinoza Liliana, Muñoz-Rodriguez Miguel Angel, Tabikh Ammar, Egido Jesus, Ortiz Alberto
Division of Nephrology and Hypertension, IIS-Fundación Jiménez Díaz, Madrid, Spain.
Blood Purif. 2014;38(3-4):224-33. doi: 10.1159/000366126. Epub 2014 Dec 19.
A positive calcium balance may contribute to vascular calcification, while a negative balance increases iPTH. We explored the impact of different dialysate calcium concentrations on bone and mineral metabolism parameters according to pre-dialysis serum calcium levels.
Fifty-six hemodialysis patients were dialyzed with 3.0 or 2.5 mEq/l dialysate [calcium] in a crossover study of two weeks. Bone mineral metabolites were measured prior to and following the hemodialysis session. A 3.0 mEq/l dialysate [calcium] increased more post-dialysis total calcium and ionized calcium than 2.5 mEq/l dialysate [calcium]. The mildest dialysis-induced changes in calcium and PTH were observed in patients with pre-dialysis serum calcium <8.75 mg/dl dialyzed with 2.5 mEq/l dialysate [calcium] and in patients with pre-dialysis serum calcium >9.15 mg/dl dialyzed with 3.0 mEq/l calcium dialysate.
In conclusion, the individualization of dialysate calcium concentration according to baseline pre-dialysis serum calcium may prevent major excursions in post-dialysis serum calcium and iPTH levels.
High calcium dialysate may increase serum calcium in hemodialysis patients, while low dialysate calcium may increase PTH. Individualization of dialysate calcium according to predialysis serum calcium levels may prevent or decrease unwanted excursions of both serum calcium and PTH.
钙平衡为正可能会导致血管钙化,而钙平衡为负则会使甲状旁腺激素升高。我们根据透析前血清钙水平,探讨了不同透析液钙浓度对骨和矿物质代谢参数的影响。
在一项为期两周的交叉研究中,56名血液透析患者分别使用3.0或2.5 mEq/l的透析液[钙]进行透析。在血液透析前后测量骨矿物质代谢产物。与2.5 mEq/l的透析液[钙]相比,3.0 mEq/l的透析液[钙]使透析后总钙和离子钙升高得更多。对于透析前血清钙<8.75 mg/dl且使用2.5 mEq/l透析液[钙]进行透析的患者,以及透析前血清钙>9.15 mg/dl且使用3.0 mEq/l钙透析液进行透析的患者,观察到透析引起的钙和甲状旁腺激素变化最为轻微。
总之,根据透析前血清钙基线个体化调整透析液钙浓度,可能会防止透析后血清钙和甲状旁腺激素水平出现大幅波动。
高钙透析液可能会使血液透析患者的血清钙升高,而低钙透析液可能会使甲状旁腺激素升高。根据透析前血清钙水平个体化调整透析液钙浓度,可能会防止或减少血清钙和甲状旁腺激素出现不必要的波动。